Open AccessComparative study of efficacy and safety of botulinum toxin a injections and subcutaneous curettage in the treatment of axillary hyperhidrosis
Author(s) -
Leelavathy Budamakuntla,
Eswari Loganathan,
Anju George,
B N Revanth,
V Sankeerth,
Sacchidananda Aradhya Sarvjnamurthy
Publication year - 2017
Publication title -
journal of cutaneous and aesthetic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.44
H-Index - 13
eISSN - 0974-5157
pISSN - 0974-2077
DOI - 10.4103/jcas.jcas_104_16
Subject(s) - medicine , curettage , hyperhidrosis , axilla , sweat , surgery , botulinum toxin , adverse effect , anesthesia , intradermal injection , subcutaneous tissue , cancer , breast cancer , immunology
Primary focal axillary hyperhidrosis is a chronic distressing disorder affecting both the sexes. When the condition is refractory to conservative management, we should go for more promising therapies like intradermal botulinum toxin A (BtxA) injections in the axilla, and surgical therapies like subcutaneous curettage of sweat glands.